A national, multi-centre, trainee-led follow-up audit of HPB malignancy launching on 10th August 2020 https://xitter.cf/t.co/JH7AUsVNMe
Birmingham, England
Joined April 2017
- Tweets280
- Following677
- Followers528
- Likes208
Pinned Tweet
Building on the success of the 1st RICOCHET collaborative study, we are excited to launch RICOCHET 2! Please look below for our visual abstract:
Register here: forms.gle/QGGe9oyhJa3HNLbU7
More information about the study is available here: ricochetstudy.wixsite.com/ri…
Ricochet Study retweeted
Very pleased to be able to share this link to the full paper. authors.elsevier.com/a/1d8Ro…
Really important to get the message about PERT prescribing out there. Thanks to @thetimes and @utv for featuring the @PancreaticCanUK #transformlivesprescribe
Ricochet Study retweeted
Really pleased to see the first output from our RICOCHET national pancreatic cancer audit. Variation and underuse of PERT despite NICE guidance. Many patients are wasting away and suffering needlessly. Thank you to all Collaborators, trainees and steering group
Thanks to the brilliant work of all our collaborators, we will soon be publishing ‘Pancreatic enzyme replacement therapy in patients with pancreatic cancer’ - #PERT is a key component of #pancreaticcancer care but we are not doing enough to provide it to our patients yet!
Despite clinical consensus that PERT is crucial for people with pancreatic cancer, & recommendations by NICE, only half are being prescribed PERT.
We are joining @PancreaticCanUK’s campaign for PERT to be made UK-wide priority in pancreatic cancer care! #TransformLivesPrescribe
Read the pre-print here: sciencedirect.com/science/ar…
(*Authorship to be corrected to fully collaborative for publication*)
Thanks to the brilliant work of all our collaborators, we will soon be publishing ‘Pancreatic enzyme replacement therapy in patients with pancreatic cancer’ - #PERT is a key component of #pancreaticcancer care but we are not doing enough to provide it to our patients yet!
Right now, half of pancreatic cancer patients are not getting the prescription they need to be able to digest their food. Together we can change this.
#RememberPERT
Thanks to the brilliant work of all our collaborators, we will soon be publishing ‘Pancreatic enzyme replacement therapy in patients with pancreatic cancer’ - #PERT is a key component of #pancreaticcancer care but we are not doing enough to provide it to our patients yet!
Ricochet Study retweeted
Really important Study, needs international collaboration to feedback rapidly the impact on patients of potential delays in cancer surgery due to COVID-19 @roux_group @RicochetStudy @AUGISt_UK @Augishealth @IHPBA @ImprovePanc @OGAAudit @GBIHPBAnews @OfficialPCA @PancreaticCanUK
Delay to surgery is major worry for patients with #cancer worldwide.
bbc.com/news/uk-wales-520382…
We need data to ensure ongoing cancer surgery is safe during #COVID19 + measure impact of on cancer patients and pathways
All cancers eligible
Sign up: globalsurg.org/cancercovidsu…
Join our committee member @siobhanmckay at the PSGBI webinar on Thursday 21st Jan pcws.e4h.co.uk to hear our most recent results!
Ricochet Study retweeted
Join us for the results of the @RicochetStudy at PSGBI webinar 21st Jan pcws.e4h.co.uk/. How long does it take from presentation to treatment plan for a patient with pancreatic cancer? @UHB_HPB @ThePancSocGBI @markataylor16 @deLiguoriCarino @DerekAOReilly @gourabsen70
31%<4 weeks
44%5-8 weeks
17%9-12 weeks
8%>13 weeks
59 votes • Final resultsPlease remember tomorrow is your last day to review the recent manuscript that we circulated to collaborators.
Please check authorship and leave any comments/suggestions by 5pm!
*All collaborators should have received an email today containing our most recent manuscript.*
There are a number of bounce backs due to emails no-longer in use. If you have not received our email, please contact us at [email protected] urgently!
You have one week, until 5pm on Sunday 15th November 2020, to add any comments to the manuscript about the data or authorship. Changes will not be possible after this time.
If your centre hasn’t yet contributed to RICOCHET 2 – the 2 year follow-up study of the RICOCHET cohort, please register via the link below! With concise data collection points for the original RICOCHET patients, this is a time-efficient study!
forms.gle/QGGe9oyhJa3HNLbU7
Watch your inboxes... Our latest manuscript looking at pancreatic enzyme replacement therapy (PERT) will be emailed to all collaborators today!!
Please review the paper; we welcome any feedback, which can be added onto the google document via the 'add comment' function.
Please submit any suggestions and triple check all authorship details for you and your team - you have until 5pm on Sunday 15th November! No changes will be accepted after this time.
Thanks for all your on-going support!
#RicochetStudy
Registrations are coming in at full speed! Don’t miss out on the opportunity in HPB collaborative research.
Sign up via this link: docs.google.com/forms/d/e/1F…
Couldn't agree more! Please sign up to this exciting collaborative follow up study via this registration link:
forms.gle/QGGe9oyhJa3HNLbU7
#HPB trainees- take note of the follow up study to @RicochetStudy Phase 1 and get your teams signed up
@Augishealth @GBIHPBAnews @markataylor16 @liveRPancSurg @UHB_HPB @gourabsen70 @DerekAOReilly @amsmithleeds @BhardwajNeil @HpbLeicester @hpbnorth